# Report composition examples

These are examples, not required shells. Preserve source meaning and apply the [composition rules](composition.md).


These are **illustrative**, not binding. They are common ways to compose the device palette for common content shapes. A given source can absolutely be composed differently if the content actually calls for it.

### Single-paper summary

**Content shape.** A long-form summary of one source paper.
**One way to compose it.** Prose-with-inline-figures is the hero. Add an outline rail only when the body has ≥6 substantive sections AND exceeds one viewport. Most single-paper summaries don't need the rail.

### Single-trial readout

**Content shape.** Headline efficacy/safety numbers from one trial, with supporting charts and tables.
**One way to compose it.** KPI tile grid as the hero (3–6 tiles across the top), chart cluster directly below, supporting tables underneath. No outline rail — the tile grid IS the outline.

### Single-drug or compound profile

**Content shape.** A reference page for one drug, compound, or target.
**One way to compose it.** Sticky infobox on the right with structured vitals; sectioned long-form body on the left (mechanism, indications, PK, AE, etc). Embed a structure gallery inline in the body if the compound has structural variants worth showing.

### Cross-entity comparison

**Content shape.** Side-by-side comparison of 2–N entities on the same dimensions.
**Two compositions, by N:**
- **2 ranked entities → parallel columns.** Each entity gets its own column and rows hold shared dimensions. Use the primary accent semantic tokens for a source-defined lead/recommended/treatment entity and orange semantic tokens for its comparator. For true peers, keep surfaces neutral and distinguish columns with names, position, and consistent structure; do not fabricate rank for color.
- **3+ entities → wide rows-by-dimensions table** . Entities as rows, dimensions as columns. Sticky first column so the entity name stays in view while scrolling sideways. One highlighted row marks the structural outlier if there is one.
- Either way: short framing paragraph above, per-row or per-column callouts below for the notable differences.


### Market or pipeline landscape

**Content shape.** A survey of a field, market, or pipeline with multiple competing assets.
**One way to compose it.** 2D positioning chart or market map as the hero at the top. Asset-card grid below, one card per entity that appeared in the chart, in roughly the same order. Brief framing paragraph between the chart and the grid to name the categories.

### Three-pillar evidence synthesis

**Content shape.** A synthesis where the structure of the argument is the point: three (or four) equal-weight evidence types side by side.
**One way to compose it.** Parallel columns as the hero — one column per evidence type, same internal anatomy in each. Framing paragraph above; synthesis paragraph below.

### Step-by-step or day-by-day instructional

**Content shape.** Sequential content where the order is the story — recipes, itineraries, training programs.
**One way to compose it.** Timeline rail as the hero. Sequential blocks march down (or across) the page. Optional shared-resources sidebar (ingredients, packing list, equipment) when there are cross-step dependencies.

### SAR optimization story

**Content shape.** A medicinal-chemistry campaign from hit to candidate.
**One way to compose it.** Structure gallery as the hero. Per-compound property chart (small radar or stat strip) per gallery tile. Optional wide comparison table below for systematic SAR data.

### Cross-species toxicology summary

**Content shape.** Comparison of safety findings between species (rat / dog / NHP).
**One way to compose it.** Wide comparison table with species as columns, organ systems or endpoints as rows. KPI tile row at top for NOAEL / MTD per species. No structure gallery; toxicology is about the findings, not the molecule.

---
